BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8183536)

  • 1. An anti-platelet activating factor antibody and its effects on platelet aggregation.
    Tatsumi N; Terano Y; Hashimoto K; Hiyoshi M; Matsuura S
    Osaka City Med J; 1993 Nov; 39(2):167-74. PubMed ID: 8183536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of anti-platelet-activating factor antibodies by the use of colloidal gold as carrier.
    Tomii A; Masugi F
    Jpn J Med Sci Biol; 1991 Apr; 44(2):75-80. PubMed ID: 1956128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-idiotypic antibodies to platelet activating factor (PAF) and their interaction with PAF receptors.
    Wang CJ; Tai HH
    J Biol Chem; 1991 Jul; 266(19):12372-8. PubMed ID: 1648095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a lyso-PAF relationship with PAF (platelet activating factor) in monosodium urate crystal-induced inflammatory exudates.
    Griswold DE; Hillegass L; Rotilio D; Mong S; Hanna N
    Eicosanoids; 1989; 2(3):151-6. PubMed ID: 2629894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal allograft platelet activating factor synthesis during acute cellular rejection.
    Mangino MJ; Anderson CB; Murphy MK; Turk J
    J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the production of platelet-activating factor by murine embryos and its putative role in the maternal physiology.
    Suzuki H; Taguchi Y; Kojima T; Nishihira J; Kanagawa H
    Biochem Mol Biol Int; 1995 Nov; 37(4):617-26. PubMed ID: 8589634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; GarcĂ­a-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis.
    Ko HM; Seo KH; Han SJ; Ahn KY; Choi IH; Koh GY; Lee HK; Ra MS; Im SY
    Cancer Res; 2002 Mar; 62(6):1809-14. PubMed ID: 11912159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a).
    Kawano Y; Furukawa Y; Fukuda J; Matsumoto H; Yuge A; Narahara H
    Am J Reprod Immunol; 2007 Nov; 58(5):434-9. PubMed ID: 17922696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antibodies to platelet activating factor.
    Smal MA; Baldo BA; Redmond JW
    Mol Immunol; 1989 Aug; 26(8):711-9. PubMed ID: 2811869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-platelet activating factor property of Rubia cordifolia Linn.
    Tripathi YB; Pandey S; Shukla SD
    Indian J Exp Biol; 1993 Jun; 31(6):533-5. PubMed ID: 8406601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.